1. Benn, P. A., Fang, M., Egan, J. F. X., Horne, D., & Collins, R. (2003). Incorporation of Inhibin-A in second-trimester screening for Down syndrome. Obstet Gynecol, 10, 451–454.
2. Benn, P., Wright, D., & Cuckle, D. (2005). Practical strategies for contingent sequential screening for Down's syndrome. Prenat Diagn, 25, 645–652.
3. Bindra, A., Heath, V., Liao, A., Spencer, K., & Nicolaides, K. H. (2002). One-stop clinic for assessment for risk for trisomy 21 at 11–14 weeks: A prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol, 20, 219–225.
4. Bray, I., Wright, D. E., Davies, C., & Hook, E. B. (1998). Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn, 18, 9–20.
5. Chen, J., Heffley, D., Beazoglou, T., & Benn, P. A. (2000). Utilization of amniocentesis by women screen-positive for Down syndrome by the second trimester triple test. Community Genet, 3, 24–30.